Literature DB >> 11768168

Use of knock-out mice to determine the molecular basis for the actions of nicotine.

M R Picciotto1, M Zoli, J P Changeux.   

Abstract

Recombinant DNA techniques have been used to identify the family of molecules that mediate nicotine's effects on the brain. Nicotine binds and activates nicotinic acetylcholine receptors (nAChRs) which are made up of combinations of individual nicotinic subunits. It is important to determine which of the many possible subunit combinations are responsible for the physiological and behavioral effects of nicotine that lead to addiction. Molecular genetic tools such as antisense strategies have been useful in elucidating the electrophysiological properties of nAChRs in different tissues. Use of knock-out mice lacking individual nAChR subunits has also begun to elucidate how nicotine exerts its actions from the molecular level to the behavioral level. Experiments using mice lacking the beta2 subunit of the nAChR have shown that binding of nicotine to receptors containing this subunit is the first step in a pathway leading to increased dopamine levels in the mesolimbic dopamine system, and ultimately to the behavioral effects of nicotine in a test of nicotine reinforcement. Mice deficient in various alpha subunits of the nAChR will identify the partners of beta2 mediating the addictive properties of nicotine. In addition, more data needs to be gathered on the electrophysiological properties of different subunit combinations, the effects of nicotine on different neurotransmitter systems and the links between the molecular biology of nicotine receptors, their physiology and the ultimate role of individual receptor subtypes in complex behaviors. Multidisciplinary approaches to nAChR function will be essential to answering these questions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11768168     DOI: 10.1080/14622299050011931

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  10 in total

1.  Of mice and intrinsic excitability: genetic background affects the size of the postburst afterhyperpolarization in CA1 pyramidal neurons.

Authors:  Shannon J Moore; Benjamin T Throesch; Geoffrey G Murphy
Journal:  J Neurophysiol       Date:  2011-06-22       Impact factor: 2.714

2.  Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.

Authors:  Arthur L Brody; Mark A Mandelkern; Edythe D London; Richard E Olmstead; Judah Farahi; David Scheibal; Jennifer Jou; Valerie Allen; Emmanuelle Tiongson; Svetlana I Chefer; Andrei O Koren; Alexey G Mukhin
Journal:  Arch Gen Psychiatry       Date:  2006-08

Review 3.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

4.  Nicotinic receptor subunit alpha5 modifies assembly, up-regulation, and response to pro-inflammatory cytokines.

Authors:  Lorise C Gahring; Scott W Rogers
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

5.  Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.

Authors:  Maria Scherma; Leigh V Panlilio; Paola Fadda; Liana Fattore; Islam Gamaleddin; Bernard Le Foll; Zuzana Justinová; Eva Mikics; Jozsef Haller; Julie Medalie; Jessica Stroik; Chanel Barnes; Sevil Yasar; Gianluigi Tanda; Daniele Piomelli; Walter Fratta; Steven R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-08-25       Impact factor: 4.030

Review 6.  The possible contribution of neuronal nicotinic acetylcholine receptors in depression.

Authors:  Daniel Bertrand
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

Review 7.  Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2019-03-18       Impact factor: 4.530

Review 8.  The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.

Authors:  Maria Scherma; Paola Fadda; Bernard Le Foll; Benoit Forget; Walter Fratta; Steven R Goldberg; Gianluigi Tanda
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 9.  Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Authors:  Enrique L M Ochoa; Jose Lasalde-Dominicci
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

10.  Varenicline in the treatment of tobacco dependence.

Authors:  Karl Fagerström; John Hughes
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.